CervoMed CRVO
NASDAQ CRVO
$2.31 +0.07 (+3.12%)
At close: Oct 23, 2026 · 4:00 PM EDT

CervoMed (CRVO) Amortization of Deferred Charges (2015 - 2018)

Updated

Analysis

CervoMed (CRVO) Amortization of Deferred Charges (2015 - 2018) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn
10 CervoMed 23.66 Mn -62.36 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2018 1,356.00
Dec 31, 2017 21,550.00
Sep 30, 2017 -73,342.00
Jun 30, 2017 28,124.00
Mar 31, 2017 57,185.00
Dec 31, 2016 31,379.00
Sep 30, 2016 2,313.00
Jun 30, 2016 1,371.00
Mar 31, 2016 3,383.00
Dec 31, 2015 5,014.00
Sep 30, 2015 68,971.00
Jun 30, 2015 34,995.00
Mar 31, 2015 56,349.00
API Access

CervoMed Amortization of Deferred Charges API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=amortization-of-deferred-charges&ticker=CRVO&period=max&api_key=YOUR_API_KEY